肿瘤浸润的双阴性调节性 T 细胞预测鼻咽癌 T 细胞免疫治疗结局
Tumor-infiltrated double-negative regulatory T cells predict outcome of T cell-based immunotherapy in nasopharyngeal carcinoma.
肿瘤细胞治疗研究
FRONTIER PAPERS
近 5 年肿瘤细胞治疗领域的研究论文。默认按评分排序(权威性 + 新鲜度)。
Tumor-infiltrated double-negative regulatory T cells predict outcome of T cell-based immunotherapy in nasopharyngeal carcinoma.
A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasophar
在高危 NPC 患者中,CCRT 联合 TILs 延长 PFS 的主要目标未能达到。
The emergence of tumor-infiltrating lymphocytes in nasopharyngeal carcinoma: Predictive value and immunotherapy implications.
共 3 条
MEMBER ACCOUNT
登录成功会直接打开下一页。